Lord’s Mark advances AI breast cancer screening towards clinical trials

Technical Committee approves final clinical trial stage; company targets regulatory clearances and commercial launch by April 2027.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.